Related references
Note: Only part of the references are listed.STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis
Wei-Hsin Lin et al.
ONCOGENE (2021)
Zinc induces reactive astrogliosis through ERK-dependent activation of Stat3 and promotes synaptic degeneration
Zhang Huiliang et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
Pui-Kei Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou et al.
MOLECULAR CANCER (2020)
VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer
Lian Lian et al.
BMC CANCER (2019)
CS2164 suppresses acute myeloid leukemia cell growth via inhibiting VEGFR2 signaling in preclinical models
Manman Deng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Gypenoside L Inhibits Proliferation of Liver and Esophageal Cancer Cells by Inducing Senescence
Jingxin Ma et al.
MOLECULES (2019)
Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models
You Zhou et al.
ANTI-CANCER DRUGS (2019)
Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors
Yongkun Sun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Follicular lymphoma
Antonino Carbone et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis
Carla Casulo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma
Victor A. Chow et al.
BLOOD (2018)
Dual or multi-targeting inhibitors: The next generation anticancer agents
Nulgumnalli Manjunathaiah Raghavendra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo
Manman Deng et al.
EXPERIMENTAL CELL RESEARCH (2018)
CS2164, a novel multi-target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti-tumor potency
You Zhou et al.
CANCER SCIENCE (2017)
Mechanisms and regulation of endothelial VEGF receptor signalling
Michael Simons et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study
H. R. Junlen et al.
LEUKEMIA (2015)
A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma
Susana M. Campos et al.
GYNECOLOGIC ONCOLOGY (2013)
The Role of Angiogenesis in Human Non-Hodgkin Lymphomas
Domenico Ribatti et al.
NEOPLASIA (2013)
Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma
J. Ruan et al.
ANNALS OF ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Identification of novel direct Stat3 target genes for control of growth and differentiation
Marylynn Snyder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Share Paper
